|国家科技期刊平台
首页|期刊导航|基础医学与临床|AP2M1抑制弥漫性大B细胞淋巴瘤细胞增殖和侵袭

AP2M1抑制弥漫性大B细胞淋巴瘤细胞增殖和侵袭OACSTPCD

AP2M1 inhibits proliferation and invasion of diffuse large B-cell lymphoma cells

中文摘要英文摘要

目的 探究接头相关蛋白质复合体 2 亚基μ1(AP2M1)对弥漫性大B细胞淋巴瘤(DLBCL)细胞增殖和侵袭的调控作用.方法 将人弥漫性大 B细胞淋巴瘤细胞系 OCI-LY8 分为对照组、NC-LV组、AP2M1-LV组.用Lipofectamine 2000进行细胞转染.四甲基偶氮唑盐(MTT)法检测细胞增殖,流式细胞仪检测细胞凋亡,Transwell小室法检测细胞迁移和侵袭.Western blot 检测 AP2M1、表皮生长因子受体(EGFR)、p-磷脂酰肌醇 3 激酶(PI3K)和p-蛋白质激酶B(AKT)蛋白表达.结果 与对照组相比,AP2M1-shRNA组细胞中AP2M1 的mRNA和蛋白相对表达量均降低(P<0.05),相对细胞活力升高(P<0.05),细胞凋亡率降低(P<0.05),迁移和侵袭细胞数量均升高(P<0.05);EGFR的蛋白相对表达量及PI3K和AKT的磷酸化水平均升高(P<0.05).与对照组相比,AP2M1-LV组细胞中AP2M1 的mRNA和蛋白相对表达量均升高(P<0.05),相对细胞活力降低(P<0.05),细胞凋亡率升高(P<0.05),迁移和侵袭细胞数量均降低(P<0.05),EGFR的蛋白相对表达量及PI3K和AKT的磷酸化水平均降低(P<0.05).结论 AP2M1 的过表达部分通过抑制EGFR/PI3K/AKT信号通路来抑制DLBCL细胞的增殖和侵袭.

Objective To evaluate the regulatory effect of the adaptor related protein complex 2 subunit μ1(AP2M1)on proliferation and invasion of diffuse large B-cell lymphoma(DLBCL).Methods Human diffuse large B-cell lymphoma cell line OCI-LY8 was aliquoted into control group,NC-shRNA group,AP2M1-shRNA group,NC-LV group,and AP2M1-LV group.Lipofectamine 2000 was used for cell transfection.Cell proliferation was detected by tetramethylazolium salt(MTT)method,apoptosis was detected by flow cytometry and cell migration and invasion were detected by Transwell assay.The protein expression of AP2M1,epidermal growth factor receptor(EGFR),p-phosphatidylinositol 3 kinase(PI3K),PI3K,p-protein kinase B(Akt)and AKT was detec-ted by Western blot.Results Compared with control group,the relative expression of AP2M1 mRNA and protein in the AP2M1-shRNA group was decreased(P<0.05).The relative cell viability was increased(P<0.05).The cell apoptosis rate was decreased(P<0.05).The counting number of migrating and invading cells was in-creased(P<0.05).The relative expression level of EGFR protein and the phosphorylation level of PI3K and AKT were increased(P<0.05).Compared with Control group,the expression of AP2M1 mRNA and protein relative ex-pression level in AP2M1-LV group was increased(P<0.05).The relative cell viability was decreased(P<0.05).The cell apoptosis rate was increased(P<0.05).The number of migrating and invading cells was decreased(P<0.05).The relative expression level of EGFR protein and the phosphorylation level of PI3K and AKT were all decreased(P<0.05).Conclusions The over-expression of AP2M1 partially inhibits the proliferation and invasion of DLBCL cells by inhibiting the EGFR/PI3K/AKT signaling pathway.

李瑗春;严学倩;范丹;及月茹;肖方;高静

空军军医大学第二附属医院 血液内科,陕西 西安 710001

临床医学

弥漫性大B细胞淋巴瘤接头相关蛋白质复合体2亚基μ1(AP2M1)表皮生长因子受体磷脂酰肌醇3激酶蛋白质激酶B

diffuse large B-cell lymphomaadaptor related protein complex 2 subunit μ1(AP2M1)epidermal growth factor recep-torphosphatidylinositol 3-kinaseprotein kinase B

《基础医学与临床》 2024 (003)

308-316 / 9

陕西省自然科学基础研究计划(2020JQ-460)

10.16352/j.issn.1001-6325.2024.03.0308

评论